About Melanoma-associated antigen 11
Melanoma-associated antigen 11 (MAGEA11) is a protein
from Homo sapiens identified by UniProt accession
P43364, 429 residues long.
MolForge cross-references it against 0 known binders and
35 disease associations.
Target properties
| Protein name | Melanoma-associated antigen 11 |
| UniProt accession | P43364 |
| Gene | MAGEA11 |
| Organism | Homo sapiens |
| Length | 429 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (35)
Diseases linked to this target (Open Targets).
- esophageal squamous cell carcinoma · score 0.09
- neoplasm · score 0.08
- head and neck squamous cell carcinoma · score 0.08
- polycystic ovary syndrome · score 0.07
- breast cancer · score 0.04
- renal cell carcinoma · score 0.03
- gonorrhea · score 0.03
- cancer · score 0.02
- gastric adenocarcinoma · score 0.02
- laryngeal squamous cell carcinoma · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P43364-F1 | alphafold | PREDICTED | 63.08 | — |
Amino-acid sequence (429 residues)
METQFRRGGL GCSPASIKRK KKREDSGDFG LQVSTMFSED DFQSTERAPY GPQLQWSQDL PRVQVFREQA NLEDRSPRRT QRITGGEQVL WGPITQIFPT VRPADLTRVI MPLEQRSQHC KPEEGLQAQE EDLGLVGAQA LQAEEQEAAF FSSTLNVGTL EELPAAESPS PPQSPQEESF SPTAMDAIFG SLSDEGSGSQ EKEGPSTSPD LIDPESFSQD ILHDKIIDLV HLLLRKYRVK GLITKAEMLG SVIKNYEDYF PEIFREASVC MQLLFGIDVK EVDPTSHSYV LVTSLNLSYD GIQCNEQSMP KSGLLIIVLG VIFMEGNCIP EEVMWEVLSI MGVYAGREHF LFGEPKRLLT QNWVQEKYLV YRQVPGTDPA CYEFLWGPRA HAETSKMKVL EYIANANGRD PTSYPSLYED ALREEGEGV
Explore Melanoma-associated antigen 11 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets